CRP activates complement through binding to the Fcγ receptor and enhancing phagocytosis of low-density lipoprotein, leading to the formation of foam cells (Zwaka et al. 2001), thus directly contributing to the development of atherosclerosis. This evidence concerns the gene CRP and atherosclerosis.